Trial Profile

A clinical study of TH-1904 for the treatment of ovarian cancer

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 16 Jul 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TH-1904 (Primary)
Indications Ovarian cancer
Focus Adverse reactions

Most Recent Events

15 Jul 2020 According to a Theratechnologies media release, the company plans to submit an IND for TH-1904, shortly after the initiation of Phase 1 clinical trial of TH-1902.
23 Apr 2020 New trial record
16 Apr 2020 According to a Theratechnologies media release, this trial will initiate shortly after the phase I trial for TH-1902.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com